[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PE20050155A1 - Nuevo compuesto intermedio para la preparacion de imidazopiridinas terapeuticamente activas - Google Patents

Nuevo compuesto intermedio para la preparacion de imidazopiridinas terapeuticamente activas

Info

Publication number
PE20050155A1
PE20050155A1 PE2004000485A PE2004000485A PE20050155A1 PE 20050155 A1 PE20050155 A1 PE 20050155A1 PE 2004000485 A PE2004000485 A PE 2004000485A PE 2004000485 A PE2004000485 A PE 2004000485A PE 20050155 A1 PE20050155 A1 PE 20050155A1
Authority
PE
Peru
Prior art keywords
formula
preparation
naphthalene
intermediate compound
acid
Prior art date
Application number
PE2004000485A
Other languages
English (en)
Inventor
Peter Zimmermann
Christian Scheufler
Bernd Muller
Bernhard Kohl
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of PE20050155A1 publication Critical patent/PE20050155A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION DE DERIVADOS TRICICLICOS DE IMIDAZOPIRIDINA UTILIZANDO COMPUESTOS INTERMEDIOS. LA INVENCION COMPRENDE SOLVATOS Y EN PARTICULAR LOS HIDRATOS DE LA SAL POR ADICION DE ACIDO 1,5-NAFTALENO DISULFONICO DEL COMPUESTO DE FORMULA (1). DICHA SAL SE PUEDE PREPARAR A PARTIR DE LOS COMPUESTOS DE FORMULA (2) POR REACCION CON EL ACIDO 1,5-NAFTALENO DISULFONICO DE FORMULA (3) Y CON 2-METOXI-ETANOL, LA REACCION DE UNA MEZCLA DE DIOLES CONDUCE A LA PRECIPITACION DE LA SAL. EL ACIDO 1,5-NAFTALENO DISULFONICO Y EL COMPUESTO DE FORMULA I FORMAN SALES POR ADICION CON DIFERENTES RELACIONES MOLARES SIENDO PREFERIDA LA RELACION SITUADA ENTRE 1 :1 Y 1,2 :1
PE2004000485A 2003-05-14 2004-05-11 Nuevo compuesto intermedio para la preparacion de imidazopiridinas terapeuticamente activas PE20050155A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03010785 2003-05-14

Publications (1)

Publication Number Publication Date
PE20050155A1 true PE20050155A1 (es) 2005-03-22

Family

ID=33442723

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2004000485A PE20050155A1 (es) 2003-05-14 2004-05-11 Nuevo compuesto intermedio para la preparacion de imidazopiridinas terapeuticamente activas

Country Status (27)

Country Link
US (1) US20060235228A1 (es)
EP (1) EP1631571B1 (es)
JP (1) JP2007502852A (es)
KR (1) KR20060012593A (es)
CN (1) CN100361991C (es)
AR (1) AR044288A1 (es)
AT (1) ATE393155T1 (es)
AU (1) AU2004238570A1 (es)
BR (1) BRPI0410084A (es)
CA (1) CA2525038A1 (es)
CL (1) CL2004001019A1 (es)
DE (1) DE602004013311D1 (es)
EA (1) EA008746B1 (es)
EC (1) ECSP056055A (es)
GE (1) GEP20084394B (es)
IS (1) IS8163A (es)
MX (1) MXPA05011859A (es)
MY (1) MY141657A (es)
NO (1) NO20055755L (es)
NZ (1) NZ543913A (es)
PE (1) PE20050155A1 (es)
RS (1) RS20050824A (es)
SA (1) SA04250092B1 (es)
TW (1) TW200503701A (es)
UA (1) UA81036C2 (es)
WO (1) WO2004101566A1 (es)
ZA (1) ZA200507741B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY189306A (en) 2015-07-30 2022-02-03 Takeda Pharmaceuticals Co Tablet
US20230060797A1 (en) * 2021-09-02 2023-03-02 Jcr Pharmaceuticals Co., Ltd. Therapeutic compound for neuronal ceroid lipofuscinosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2011078C3 (de) * 1970-03-09 1974-11-14 Goedecke Ag, 1000 Berlin Verfahren zur Reinigung von Hexetidin
ID28896A (id) * 1998-09-23 2001-07-12 Byk Gulden Lomberg Chem Fab Tetrahidro pirido eter
ES2253376T3 (es) * 2000-03-29 2006-06-01 Altana Pharma Ag Profarmacos de derivados de imidazopiridina.

Also Published As

Publication number Publication date
BRPI0410084A (pt) 2006-05-16
MXPA05011859A (es) 2006-02-17
UA81036C2 (en) 2007-11-26
EP1631571A1 (en) 2006-03-08
EA200501691A1 (ru) 2006-06-30
TW200503701A (en) 2005-02-01
CA2525038A1 (en) 2004-11-25
AU2004238570A1 (en) 2004-11-25
EA008746B1 (ru) 2007-08-31
EP1631571B1 (en) 2008-04-23
WO2004101566A8 (en) 2007-04-26
KR20060012593A (ko) 2006-02-08
DE602004013311D1 (de) 2008-06-05
SA04250092B1 (ar) 2008-05-04
ZA200507741B (en) 2008-08-27
CL2004001019A1 (es) 2005-03-04
CN1780839A (zh) 2006-05-31
NO20055755L (no) 2005-12-05
AR044288A1 (es) 2005-09-07
US20060235228A1 (en) 2006-10-19
CN100361991C (zh) 2008-01-16
ATE393155T1 (de) 2008-05-15
JP2007502852A (ja) 2007-02-15
ECSP056055A (es) 2006-01-27
MY141657A (en) 2010-05-31
NZ543913A (en) 2008-02-29
GEP20084394B (en) 2008-06-10
WO2004101566A1 (en) 2004-11-25
IS8163A (is) 2005-12-01
RS20050824A (en) 2007-12-31

Similar Documents

Publication Publication Date Title
AR058293A1 (es) Sales profarmacos y formulaciones de 1-[5-(4-amino-7-isopropil-7h-pirrolo[2,3-d]pirimidin-5-carbonil)-2-metoxi-fenil]-3-(2,4-dicloro-fenil)-urea
TW200744587A (en) Azaindole derivatives exhibiting PGD2 receptor antagonism
GB201201744D0 (en) Novel compounds
UY30440A1 (es) Nuevos compuestos
RS51210B (sr) Dobijanje pregaballina i srodnih jedinjenja
BRPI0608732A2 (pt) composto ou um sal, hidrato, solvato, complexo ou pró-droga farmaceuticamente aceitável do mesmo, sal de um composto, processo para a preparação de um composto, uso de um composto, composição farmacêutica, e, produto
EA201000805A1 (ru) Бис-(сульфониламино)производные в терапии 066
WO2007022934A3 (en) Azabicyclo (3, 1, 0) hexan derivatives useful as modulators of dopamine d3 receptors
AR067757A1 (es) Derivados de imidazo[4,5-c]piridin-2-ona, composiciones farmaceuticas que los contienen, procedimiento para su preparacion y uso de los mismos como agentes antivirales.
AR052404A1 (es) Hidratos y polimorfos de 4-(((7r)-8-ciclopentil-7-etil-5,6,7,8-tetrahidro-5-metil-6-oxo-2-pteridinil)amino)-3- metoxi-n-(1-metil-4-piperidinil)-benzamida, procedimiento para su preparacion y su uso como farmaco
PE20011371A1 (es) Derivados de 3-(3-isopropil-5-metil-4h-1,2,4-triazol-4-il)-exo-8-azabiciclo[3.2.1]octano como antagonistas de los receptores de quimiocina ccr5
AR057072A1 (es) Compuestos quimicos derivados de 2-azetidinona, formulacion farmaceutica y un proceso de preparacion del compuesto
TW200745029A (en) Sulfonamide derivatives exhibiting PGD2 receptor antagonism
TW200734322A (en) Indole derivatives exhibiting PGD2 receptor antagonism
NO20083708L (no) 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
ECSP045078A (es) Tiofen- y tiazolsulfonamidas como agentes antineoplásicos
BRPI0617918B8 (pt) compostos de fórmula (i) e seu uso, medicamentos e composição farmacêutica
RU2008127445A (ru) Бициклические гетероциклические соединения в качестве противовоспалительных или антиаллергических агентов
PE20110147A1 (es) Composicion y proceso - 356
PA8810101A1 (es) Derivados de imidazo[1,2-a]piridin-2-carboxamidas, su preparación y su aplicación en terapéutica
PE20070415A1 (es) PROCEDIMIENTO DE PREPARACION PARA {6-[4-(4-ETIL-PIPERAZIN-1-ILMETIL)-FENIL]-7H-PIRROLO-[2,3-d]-PIRIMIDIN-4-IL]-((R)-1-FENIL-ETIL)-AMINA
EP2005954A4 (en) KIT FOR CANCER THERAPY AND PHARMACEUTICAL COMPOSITION FOR CANCER THERAPY
AR039935A1 (es) Formulacion farmaceutica de liberacion inmediata
EP1599201A4 (en) SELECTIVE MODULATORS OF NON-STEROIDAL GLUCOCORTICOID RECEPTORS
PE20050155A1 (es) Nuevo compuesto intermedio para la preparacion de imidazopiridinas terapeuticamente activas

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed